781 related articles for article (PubMed ID: 27321181)
21. Purinergic signalling and immune cells.
Burnstock G; Boeynaems JM
Purinergic Signal; 2014 Dec; 10(4):529-64. PubMed ID: 25352330
[TBL] [Abstract][Full Text] [Related]
22. The purinergic neurotransmitter revisited: a single substance or multiple players?
Mutafova-Yambolieva VN; Durnin L
Pharmacol Ther; 2014 Nov; 144(2):162-91. PubMed ID: 24887688
[TBL] [Abstract][Full Text] [Related]
23. EVALUATION OF COMPONENTS OF THE EXTRACELLULAR PURINERGIC SIGNALING SYSTEM IN HUMAN SEPSIS.
Lovászi M; Németh ZH; Kelestemur T; Sánchez IV; Antonioli L; Pacher P; Wagener G; Haskó G
Shock; 2024 Apr; 61(4):527-540. PubMed ID: 37752081
[TBL] [Abstract][Full Text] [Related]
24. Purinergic Regulation of Endothelial Barrier Function.
Aslam M; Gündüz D; Troidl C; Heger J; Hamm CW; Schulz R
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530557
[TBL] [Abstract][Full Text] [Related]
25. Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation.
Zhang X; Zhang M; Laties AM; Mitchell CH
J Neurochem; 2006 Jul; 98(2):566-75. PubMed ID: 16805847
[TBL] [Abstract][Full Text] [Related]
26. The trophic effects of purines and purinergic signaling in pathologic reactions of astrocytes.
Rathbone MP; Middlemiss P; Andrew C; Caciagli F; Ciccarelli R; Di Iorio P; Huang R
Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S36-45. PubMed ID: 9769028
[TBL] [Abstract][Full Text] [Related]
27. Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium.
Bergamin LS; Braganhol E; Figueiró F; Casali EA; Zanin RF; Sévigny J; Battastini AM
J Cell Biochem; 2015 May; 116(5):721-9. PubMed ID: 25546398
[TBL] [Abstract][Full Text] [Related]
28. Immunoregulatory activity of adenosine and its role in human cancer progression.
Muller-Haegele S; Muller L; Whiteside TL
Expert Rev Clin Immunol; 2014 Jul; 10(7):897-914. PubMed ID: 24871693
[TBL] [Abstract][Full Text] [Related]
29. [Progress on role of extracellular ATP and its metabolite adenosine in immunoregulation: Review].
Wang C; Yin Q; Su Z; Xia L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1134-1140. PubMed ID: 33325366
[TBL] [Abstract][Full Text] [Related]
30. Targeting Adenosine Receptor Signaling in Cancer Immunotherapy.
Sek K; Mølck C; Stewart GD; Kats L; Darcy PK; Beavis PA
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513816
[TBL] [Abstract][Full Text] [Related]
31. Small molecular CD73 inhibitors: Recent progress and future perspectives.
Ge GH; Wang QY; Zhang ZH; Zhang X; Guo S; Zhang TJ; Meng FH
Eur J Med Chem; 2024 Jan; 264():116028. PubMed ID: 38086190
[TBL] [Abstract][Full Text] [Related]
32. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.
Chiarella AM; Ryu YK; Manji GA; Rustgi AK
Trends Cancer; 2021 Aug; 7(8):731-750. PubMed ID: 34074623
[TBL] [Abstract][Full Text] [Related]
33. Purinergic signalling and cancer.
Burnstock G; Di Virgilio F
Purinergic Signal; 2013 Dec; 9(4):491-540. PubMed ID: 23797685
[TBL] [Abstract][Full Text] [Related]
34. Eosinophils and Purinergic Signaling in Health and Disease.
Ferrari D; Vuerich M; Casciano F; Longhi MS; Melloni E; Secchiero P; Zech A; Robson SC; Müller T; Idzko M
Front Immunol; 2020; 11():1339. PubMed ID: 32733449
[TBL] [Abstract][Full Text] [Related]
35. Neutrophils: fast and furious-the nucleotide pathway.
Rubenich DS; de Souza PO; Omizzollo N; Lenz GS; Sevigny J; Braganhol E
Purinergic Signal; 2021 Sep; 17(3):371-383. PubMed ID: 33913070
[TBL] [Abstract][Full Text] [Related]
36. Purinergic signaling in B cells.
Przybyła T; Sakowicz-Burkiewicz M; Pawełczyk T
Acta Biochim Pol; 2018; 65(1):1-7. PubMed ID: 29360885
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models
Demeules M; Scarpitta A; Hardet R; Gondé H; Abad C; Blandin M; Menzel S; Duan Y; Rissiek B; Magnus T; Mann AM; Koch-Nolte F; Adriouch S
Front Immunol; 2022; 13():1012534. PubMed ID: 36341324
[TBL] [Abstract][Full Text] [Related]
38. Purinergic receptors in psychiatric disorders.
Krügel U
Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
[TBL] [Abstract][Full Text] [Related]
39. Extracellular adenosine triphosphate and adenosine in cancer.
Stagg J; Smyth MJ
Oncogene; 2010 Sep; 29(39):5346-58. PubMed ID: 20661219
[TBL] [Abstract][Full Text] [Related]
40. Purinergic signaling in hepatic disease.
Velázquez-Miranda E; Díaz-Muñoz M; Vázquez-Cuevas FG
Purinergic Signal; 2019 Dec; 15(4):477-489. PubMed ID: 31576486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
